Shots:

• The US FDA has issued a EUA for the CLINITEST Rapid COVID-19 Antigen Self-Test in individuals aged ≥14yrs. The company provides access globally to a new self-test for individuals, families, and businesses to prevent COVID-19
• The nasal swab test helps for the rapid detection of SARS-CoV-2 which is expected to be available in January & provides the results in just 15 min.
• The product is highly accurate with 86.5% sensitivity and a specificity of 99.3% compared to the nucleic acid (PCR) detection method. Additionally, clinical data has been established under Siemens Healthineers participation in the NIH RADx Independent Test Assessment Program (ITAP)

Ref: Businesswire | Image: Siemens